Clinical Trials Directory

Trials / Unknown

UnknownNCT02178761

Imaging and Interventional Study for Erectile Dysfunction and Lower Urinary Tract Symptoms

Comprehensive Imaging and Interventional Therapy Studies for Arteriogenic Erectile Dysfunction and Lower Urinary Tract Symptoms: A Multi-modality, Multi-Specialty Collaborative Study (PERFECT Program)

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
300 (estimated)
Sponsor
National Taiwan University Hospital · Academic / Other
Sex
Male
Age
20 Years
Healthy volunteers
Not accepted

Summary

Erectile dysfunction is highly prevalent as men grow older. Among the various causes of erectile dysfunction, it has been shown that pelvic arterial insufficiency plays a very important role. The investigators have recently developed the first imaging analytical algorithm by using the abdominal/pelvis multidetector computed tomographic (MDCT) angiography to delineate the whole arterial system supplying the penis. To establish a comprehensive, cutting-edge diagnostic and interventional therapeutic program for erectile dysfunction, the investigators therefore design this series of studies by including experts from Urology, Radiology, and Cardiology. This research project (PERFECT program) includes the following 4 sub-studies: 1) differential frequency of obstructive pelvic arterial lesions in coronary artery disease patients with and without erectile dysfunction/lower urinary tract symptoms (LUTS), 2) differential frequency of obstructive pelvic arterial lesions in patients with vascular risk factors and with or without erectile dysfunction/LUTS, 3) safety, feasibility, and efficacy of comprehensive pelvic angioplasty (with various interventional strategies/instruments) for patients with erectile dysfunction/LUTS and pelvic obstructive arterial disease: proof-of-concept study; and 4) efficacy and safety of comprehensive pelvic angioplasty (with various interventional strategies/instruments) for patients with erectile dysfunction/LUTS and pelvic obstructive arterial disease: a randomized controlled trial.

Conditions

Interventions

TypeNameDescription
DEVICEdrug-eluting balloonangioplasty completed with drug-eluting balloons
DEVICEbiodegradable vascular scaffold stentStenting with biodegradable vascular scaffold stents
DEVICEApex™ PTCA Dilatation Catheterplain old balloon angioplasty alone
DEVICEStent Systemstenting with either bare-metal stents or drug-eluting stents

Timeline

Start date
2012-10-01
Primary completion
2016-06-01
Completion
2016-06-01
First posted
2014-07-01
Last updated
2014-07-01

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT02178761. Inclusion in this directory is not an endorsement.